CClinicalTrials.gg
Status unknownNCT04285502Updated Feb 26, 2020

Comparison of Postoperative Drain Insertion Versus No Drain Insertion In Total Laparoscopic Hysterectomy

An interventional study of SURGICAL DRAIN in TOTAL ABDOMINAL HYSTERECTOMY, sponsored by Zeynep Kamil Maternity and Pediatric Research and Training Hospital. Status unknown at 2 sites in Turkey. Open to female participants aged 40 Years to 70 Years. Per ClinicalTrials.gov, last updated 2020-02-26.

Sponsored by Zeynep Kamil Maternity and Pediatric Research and Training Hospital · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Feb 2020), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
40 Years to 70 Years
Sex
Female
01

Study summary

This prospective randomized controlled trial was planned to be conducted among total laparoscopic hysterectomies performed at Zeynep Kamil Maternity and Children's Diseases Training and Research Hospital during one year period. The effect of drain insertion during the surgery will be assessed by this clinical trial. Patients will be assigned into two groups as cases and controls. Patients who will a drain inserted will be considered as case group and patients without a drain will be considered as control group. Patients will be evaluated according to their post operative VAS scores, hematocrit levels, their drainage volume and manifestation of an infection after the surgery.

Read the detailed description

This prospective randomized controlled trial was planned to be conducted from February 2020 to February 2021 and included total laparoscopic hysterectomies performed at Zeynep Kamil Maternity and Children's Diseases Training and Research Hospital during the study period.

Surgeries on patients with existing comorbidity, with underlying malignant conditions, patients diagnosed deeply infiltrative endometriosis during surgery and patients who undergo multiple surgeries will be excluded from the study.

Clinical and descriptive data will be collected from both paper and electronic records, including the pain of the patient, the need for analgesia at the 6th-12th and 24th hour during the post-operative period. Visual analog scale (VAS) will be used to track the pain progression of the patients. Intraabdominal bleeding will be determined by measuring the hematocrit levels and drainage volume at postoperative day 1. Patients will also be assessed according to manifesting an infection in both the short term and long term.

Patients who will a drain inserted will be considered as case group and patients without a drain will be considered as control group. Data will be analyzed using the Statistical Package for Social Sciences (SPSS). A Chi-squared test will be used to evaluate the significance of the associations between variables. Continuous variables will be displayed as means and standard deviations. A P value of ≤0.050 will be considered as significant.

This study obtained ethical approval from the Medical Research \& Ethics Committee of Zeynep Kamil Maternity and Children's Diseases Training and Research Hospital.

02

Conditions studied

  • TOTAL ABDOMINAL HYSTERECTOMY

Keywords

  • surgical drain
  • visual analog scale
  • hematocrit
03

In context

Lead sponsor

Zeynep Kamil Maternity and Pediatric Research and Training Hospital is the lead sponsor of 38 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 70 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Female
  • age between 40-70
  • undergoing surgery for a benign condition
  • having an abdominal surgery for the first time

Exclusion criteria

Exclusion Criteria:

  • existing comorbidity
  • with underlying malignant conditions
  • patients diagnosed deeply infiltrative endometriosis during surgery
  • patients who undergone multiple surgeries
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • No intervention
    CONTROL GROUP

    patients without a drain

  • Experimental
    CASE GROUP

    Patients a drain inserted

    Procedure: SURGICAL DRAIN

Interventions

  • ProcedureSURGICAL DRAIN

    A surgical drain is a tube used to remove blood, abscess and any type of fluid at the site of the place it is inserted

06

What researchers measure

Primary outcomes

  1. analgesia need at the post-operative period

    patient need for analgesia during post operative first day

    Time frame: post operative 6. hour

  2. hematocrit levels

    patient hematocrit level at post operative day 1

    Time frame: post operative first day

  3. drainage volume

    drainage volume at postoperative day

    Time frame: post operative first day

  4. post operative infection

    manifesting an post operative infection in short term and long term

    Time frame: post operative first day and post operative 1. week

  5. pain post operative 6.-12. and 24. hour

    will be measured using VAS score

    Time frame: pain

Secondary outcomes

  1. analgesia need at the post-operative 6. hour

    patient need for analgesia

    Time frame: post-operative 6. hour

  2. analgesia need at the post-operative 12. hour

    patient need for analgesia

    Time frame: post-operative 12. hour

07

Study locations

2 of 2 sites recruiting
  • Zeynep Kamil Maternity and Children Training and Research Hospital
    Istanbul, Turkey
    Recruiting
  • Zeynep Kamil
    Istanbul, Turkey
    Recruiting
08

References and documents

Publications

  • Weston M, Soyer P, Barral M, Dohan A, Pierre S, Rabei R, Garcia-Reyes K, Kohi MP. Role of Interventional Procedures in Obstetrics and Gynecology. Radiol Clin North Am. 2020 Mar;58(2):445-462. doi: 10.1016/j.rcl.2019.11.006. PubMed 32044017 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 26, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04285502
Lead sponsor
Zeynep Kamil Maternity and Pediatric Research and Training Hospital
Responsible party
enis ozkaya (ASSOCIATED PROFESSOR, Zeynep Kamil Maternity and Pediatric Research and Training Hospital) — Principal investigator
First posted
Feb 26, 2020
Start date
Mar 1, 2020 (estimated)
Primary completion
Nov 1, 2020 (estimated)
Completion
Feb 1, 2021 (estimated)
Last update
Feb 26, 2020

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Feb 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion